Herbas VPB

Print
EN | LT
LT - N-[2,4-Bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4- oksochinolin-3-karboksamido farmacinės kompozicijos ir jų įvedimas
EN - PHARMACEUTICAL COMPOSITION OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4- OXOQUINOLINE-3-CARBOXAMIDE AND ADMINISTRATION THEREOF

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 47/32 (2006.01)
A61K 9/16 (2006.01)
A61K 9/20 (2006.01)
A61K 9/28 (2006.01)
A61K 31/47 (2006.01)
European patent
(11) Number of the document 2328618
(13) Kind of document T
(96) European patent application number 09789125.3
Date of filing the European patent application 2009-08-13
(97) Date of publication of the European application 2011-06-08
(45) Date of publication and mention of the grant of the patent 2017-11-29
(46) Date of publication of the claims translation 2018-03-26
PCT application
(86) Number PCT/US2009/004629
Date 2009-08-13
PCT application publication
(87) Number WO 2010/019239
Date 2010-02-18
Priority applications
(30) Number Date Country code
146163 P 2009-01-21 US
88801 P 2008-08-14 US
183345 P 2009-06-02 US
88704 P 2008-08-13 US
90096 P 2008-08-19 US
181527 P 2009-05-27 US
Inventors
(72)
ROWE, William, US
HURTER, Patricia, US
YOUNG, Christopher, US
DINEHART, Kirk, US
VERWIJS, Marinus, Jacobus, US
OVERHOFF, Kirk, US
GROOTENHUIS, Peter, D., J., US
BOTFIELD, Martyn, US
GROSSI, Alfredo, US
Grantee
(73) Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) N-[2,4-Bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4- oksochinolin-3-karboksamido farmacinės kompozicijos ir jų įvedimas
  PHARMACEUTICAL COMPOSITION OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4- OXOQUINOLINE-3-CARBOXAMIDE AND ADMINISTRATION THEREOF
Last renewal fee
Payment date Validity (years) Amount
2024-07-18 16 347.00 EUR
Next renewal fee
2025-08-13